Topic prioritisation

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Decision date

Decision date

Prioritisation programme

Prioritisation programme

Decision

Decision

Showing 51 to 60 of 379

TitlePrioritisation programmeDecisionDecision date
Tolebrutinib for treating primary progressive multiple sclerosis [TSID12166]None selectedAwaiting decision
Dostarlimab for previously treated advanced or recurrent endometrial cancer with high microsatellite instability or mismatch repair deficiency (MA review of TA779) [ID6326]None selectedAwaiting decision
Sulthiame for treating self-limiting epilepsy with centrotemporal spikes in children TSID 12106None selectedNot selected
Apremilast for treating juvenile psoriatic arthritis in people 5 to 17 years [TSID12089]None selectedNot selected
Botulinum neurotoxin type E for treating moderate to severe glabellar lines [TSID12155]None selectedNot selected
Doravirine–islatravir for treating HIV-1 in people with virological suppression on antiretroviral therapy [TSID12173]None selectedNot selected
Orforglipron for treating type 2 diabetes [TSID12130]None selectedNot selected
Ocrelizumab for treating relapsing–remitting multiple sclerosis in people 10 to 17 years [TSID12164]None selectedNot selected
Botulinum toxin injection to cricopharyngeal muscle for retrograde cricopharyngeal dysfunction (RCPD)None selectedNot selected
AHEAD implants for external ear prosthesisNone selectedNot selected

Results per page

  1. 10
  2. 25
  3. 50
  4. All